Clinical Trials Logo

Acute Migraine Headache clinical trials

View clinical trials related to Acute Migraine Headache.

Filter by:
  • None
  • Page 1

NCT ID: NCT05983354 Not yet recruiting - Clinical trials for Acute Migraine Headache

Oral Medications for the Management of Acute Migraine Headache in the Emergency Department

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The goal of this pilot randomized control trial is to assess the feasibility of our patient recruitment and data collection strategy ahead of a full scale RCT investigating the efficacy of oral v. parenteral medications in the management of acute migraine headaches in the emergency department. Patients will be randomly assigned to receive either (A) standard medical therapy for the treatment of acute migraine headache (metoclopramide and ketorolac IV) and oral placebo or (B) oral metoclopramide and ibuprofen with normal saline IV. Primary outcome measures are recruitment rate and improvement in pain score at 60 minutes from medication administration.

NCT ID: NCT03145467 Completed - Clinical trials for Acute Migraine Headache

Comparison of Oral Paracetamol and Zolmitriptan Efficacy in the Treatment of Acute Migraine in Emergency Department

Start date: January 2016
Phase: Phase 4
Study type: Interventional

Migraine is a chronic and sometimes progressive disorder, characterized by headache, recurrent episodes, and other associated symptoms. Migraine is the most common cause of headache among patients who applied to emergency services. The purpose of the investigators is to compare the efficacy of oral paracetamol and zolmitriptan in the treatment of acute migraine headache in an emergency department.

NCT ID: NCT00573599 Completed - Clinical trials for Acute Migraine Headache

Prochlorperazine vs Imitrex for Acute Migraine in the Emergency Department

Start date: February 2007
Phase: N/A
Study type: Interventional

ED patients with acute migraine will be randomized to either prochlorperazine and Bendaryl OR imitrex. VAS for pain will be monitored, along with side effects. Primary outcome measure is improvement in pain scales between the groups.